Tenn. Appeals Court Won't Halt Endo's $2.4B Opioid Trial
A Tennessee appellate court on Friday refused to stay lower court proceedings, including a trial set for July 26, that will determine whether Endo Pharmaceuticals should pay $2.4 billion in damages...To view the full article, register now.
Already a subscriber? Click here to view full article